Source comparison
Hexarelin Side Effects: Dosing Comparison
Before interpreting adverse event data, researchers must understand that hexarelin side effects scale non-linearly with dose. A 100 mcg dose doesn't produce twice the side effects of a 50 mcg dose. It produces a different hormonal profile entirely. 50–100 mcg
This comparison does not assign a generated winner or score.
- Before interpreting adverse event data, researchers must understand that hexarelin side effects scale non-linearly with dose. A 100 mcg dose doesn't produce twice the side effects of a 50 mcg dose. It produces a different hormonal profile entirely.
- 50–100 mcg
- Moderate (2–3× baseline)
- Minimal (<30% increase)
- Minimal (<40% increase)
- 14–21 days
- Low-risk GH pulse studies, exploratory work
- 100–200 mcg
- High (4–6× baseline)
- Moderate (50–100% increase)
- Moderate (60–120% increase)
- 10–14 days
- Standard GH secretagogue research, body composition trials
- 200–400 mcg
- Very High (6–10× baseline)
- High (100–200% increase)
- High (150–250% increase)
- 7–10 days
- Acute GH challenge tests, pharmacokinetic studies, not suitable for chronic use
- >400 mcg
- Maximal but diminishing returns
- Very High (>200% increase)
- Very High (>300% increase)
- <7 days
- Diagnostic use only; adverse event risk outweighs research value
- Research teams operating at the 100–200 mcg range. The most common dosing window. Should anticipate moderate cortisol and prolactin disruption by week two, with receptor desensitization limiting GH output shortly thereafter. Increasing dose beyond 200 mcg doesn't extend the efficacy window; it collapses it faster while amplifying stress-axis activation. The peptide's therapeutic index narrows sharply above 200 mcg per dose.